Ancient double-blind phase II studies aimed at assessing the possible therapeutic role of proinsulin were prematurely interrupted due to the occurrence of macrovascular events in the proinsulin arm, in newly diagnosed patients with DM [28]. Here, INS is linked to diabetes mellitus.